Granulocyte Macrophage Colony Stimulating Factor Market Report

Europe Granulocyte Macrophage Colony Stimulating Factor Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 03, 2020
  • PAGES：208
  • REPORT CODE：GMM459222
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Granulocyte Macrophage Colony Stimulating Factor market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Granulocyte Macrophage Colony Stimulating Factor Market Segmentations:

    By Player:

    • BriaCell Therapeutics Corp

    • Morphotek Inc

    • Aduro BioTech Inc

    • Sillajen Biotherapeutics

    • Amgen Inc

    • GlaxoSmithKline Plc

    • Takeda Pharmaceutical Co Ltd

    • Mologen AG

    • Humanigen Inc

    • Cold Genesys Inc

    By Type:

    • CG-0070

    • Gimsilumab

    • GSK-3196165

    • Lenzilumab

    • MGN-1601

    • Others

    By End-User:

    • Solid Tumor

    • Lymphoma

    • Kidney Cancer

    • Lung Disease

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Granulocyte Macrophage Colony Stimulating Factor Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of CG-0070 from 2014 to 2026

    • 1.3.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Gimsilumab from 2014 to 2026

    • 1.3.3 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of GSK-3196165 from 2014 to 2026

    • 1.3.4 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lenzilumab from 2014 to 2026

    • 1.3.5 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of MGN-1601 from 2014 to 2026

    • 1.3.6 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Solid Tumor from 2014 to 2026

    • 1.4.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • 1.4.3 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Kidney Cancer from 2014 to 2026

    • 1.4.4 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lung Disease from 2014 to 2026

    • 1.4.5 Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Granulocyte Macrophage Colony Stimulating Factor Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Granulocyte Macrophage Colony Stimulating Factor by Major Types

      • 3.4.1 Market Size and Growth Rate of CG-0070

      • 3.4.2 Market Size and Growth Rate of Gimsilumab

      • 3.4.3 Market Size and Growth Rate of GSK-3196165

      • 3.4.4 Market Size and Growth Rate of Lenzilumab

      • 3.4.5 Market Size and Growth Rate of MGN-1601

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Granulocyte Macrophage Colony Stimulating Factor Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Granulocyte Macrophage Colony Stimulating Factor by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor for Solid Tumor

      • 4.4.2 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor for Lymphoma

      • 4.4.3 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor for Kidney Cancer

      • 4.4.4 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor for Lung Disease

      • 4.4.5 Market Size and Growth Rate of Granulocyte Macrophage Colony Stimulating Factor for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Granulocyte Macrophage Colony Stimulating Factor Production Analysis by Top Regions

    • 5.2 Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Analysis by Top Regions

    • 5.3 Europe Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.3 France Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    6 Product Circulation of Granulocyte Macrophage Colony Stimulating Factor Market among Top Countries

    • 6.1 Top 5 Export Countries in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 7.1 Germany Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 7.2 Germany Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    8. UK Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 8.1 UK Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 8.2 UK Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    9. France Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 9.1 France Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 9.2 France Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    10. Italy Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 10.1 Italy Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 10.2 Italy Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    11. Spain Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 11.1 Spain Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 11.2 Spain Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    12. Poland Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 12.1 Poland Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 12.2 Poland Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    13. Russia Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 13.1 Russia Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 13.2 Russia Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    14. Switzerland Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 14.1 Switzerland Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 14.2 Switzerland Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    15. Turkey Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 15.1 Turkey Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 15.2 Turkey Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Top Countries

      • 16.3.1 Denmark Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 16.3.2 Finland Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 16.3.3 Norway Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 16.3.4 Sweden Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 16.3.6 Iceland Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Top Countries

      • 17.3.1 Belgium Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 17.3.2 Netherlands Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 17.3.3 Luxembourg Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Landscape Analysis by Top Countries

      • 18.3.1 Estonia Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 18.3.2 Latvia Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

      • 18.3.3 Lithuania Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 BriaCell Therapeutics Corp

      • 19.1.1 BriaCell Therapeutics Corp Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Morphotek Inc

      • 19.2.1 Morphotek Inc Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Aduro BioTech Inc

      • 19.3.1 Aduro BioTech Inc Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Sillajen Biotherapeutics

      • 19.4.1 Sillajen Biotherapeutics Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Amgen Inc

      • 19.5.1 Amgen Inc Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 GlaxoSmithKline Plc

      • 19.6.1 GlaxoSmithKline Plc Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Takeda Pharmaceutical Co Ltd

      • 19.7.1 Takeda Pharmaceutical Co Ltd Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Mologen AG

      • 19.8.1 Mologen AG Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Humanigen Inc

      • 19.9.1 Humanigen Inc Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Cold Genesys Inc

      • 19.10.1 Cold Genesys Inc Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 98 Figures and 144 Tables)

    • Figure Product Picture

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of CG-0070 from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Gimsilumab from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of GSK-3196165 from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lenzilumab from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of MGN-1601 from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Solid Tumor from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Kidney Cancer from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lung Disease from 2014 to 2026

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure UK Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure France Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Granulocyte Macrophage Colony Stimulating Factor Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Granulocyte Macrophage Colony Stimulating Factor

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Granulocyte Macrophage Colony Stimulating Factor by Different Types from 2014 to 2026

    • Table Consumption Share of Granulocyte Macrophage Colony Stimulating Factor by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of CG-0070

    • Figure Market Size and Growth Rate of Gimsilumab

    • Figure Market Size and Growth Rate of GSK-3196165

    • Figure Market Size and Growth Rate of Lenzilumab

    • Figure Market Size and Growth Rate of MGN-1601

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Granulocyte Macrophage Colony Stimulating Factor by Different End-Users from 2014 to 2026

    • Table Consumption Share of Granulocyte Macrophage Colony Stimulating Factor by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Solid Tumor

    • Figure Market Size and Growth Rate of Lymphoma

    • Figure Market Size and Growth Rate of Kidney Cancer

    • Figure Market Size and Growth Rate of Lung Disease

    • Figure Market Size and Growth Rate of Others

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Production by Major Regions

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Production Share by Major Regions

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Production Share by Major Countries and Regions in 2014

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption by Major Regions

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Regions

    • Table Germany Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table UK Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table France Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Italy Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Spain Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Poland Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Russia Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Switzerland Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Turkey Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Granulocyte Macrophage Colony Stimulating Factor Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Germany Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Germany Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Germany Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table UK Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table UK Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table UK Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table UK Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table France Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table France Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table France Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table France Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Italy Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Italy Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Italy Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Italy Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Spain Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Spain Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Spain Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Spain Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Poland Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Poland Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Poland Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Poland Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Russia Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Russia Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Russia Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Russia Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Switzerland Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Switzerland Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Switzerland Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Turkey Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Turkey Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Turkey Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Granulocyte Macrophage Colony Stimulating Factor Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Granulocyte Macrophage Colony Stimulating Factor Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of BriaCell Therapeutics Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BriaCell Therapeutics Corp

    • Figure Sales and Growth Rate Analysis of BriaCell Therapeutics Corp

    • Figure Revenue and Market Share Analysis of BriaCell Therapeutics Corp

    • Table Product and Service Introduction of BriaCell Therapeutics Corp

    • Table Company Profile and Development Status of Morphotek Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Morphotek Inc

    • Figure Sales and Growth Rate Analysis of Morphotek Inc

    • Figure Revenue and Market Share Analysis of Morphotek Inc

    • Table Product and Service Introduction of Morphotek Inc

    • Table Company Profile and Development Status of Aduro BioTech Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aduro BioTech Inc

    • Figure Sales and Growth Rate Analysis of Aduro BioTech Inc

    • Figure Revenue and Market Share Analysis of Aduro BioTech Inc

    • Table Product and Service Introduction of Aduro BioTech Inc

    • Table Company Profile and Development Status of Sillajen Biotherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sillajen Biotherapeutics

    • Figure Sales and Growth Rate Analysis of Sillajen Biotherapeutics

    • Figure Revenue and Market Share Analysis of Sillajen Biotherapeutics

    • Table Product and Service Introduction of Sillajen Biotherapeutics

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Takeda Pharmaceutical Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Co Ltd

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Co Ltd

    • Table Product and Service Introduction of Takeda Pharmaceutical Co Ltd

    • Table Company Profile and Development Status of Mologen AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mologen AG

    • Figure Sales and Growth Rate Analysis of Mologen AG

    • Figure Revenue and Market Share Analysis of Mologen AG

    • Table Product and Service Introduction of Mologen AG

    • Table Company Profile and Development Status of Humanigen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Humanigen Inc

    • Figure Sales and Growth Rate Analysis of Humanigen Inc

    • Figure Revenue and Market Share Analysis of Humanigen Inc

    • Table Product and Service Introduction of Humanigen Inc

    • Table Company Profile and Development Status of Cold Genesys Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cold Genesys Inc

    • Figure Sales and Growth Rate Analysis of Cold Genesys Inc

    • Figure Revenue and Market Share Analysis of Cold Genesys Inc

    • Table Product and Service Introduction of Cold Genesys Inc

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US